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Introduction: Prolonged conventional cardiopulmonary resuscitation (CCPR) is associated with a poor prognosis in
out-of-hospital cardiac arrest (OHCA) patients. Alternative methods can be needed to improve the outcome in
patients with prolonged CCPR and extracorporeal cardiopulmonary resuscitation (ECPR) can be considered as an
alternative method. The objectives of this study were to estimate the optimal duration of CPR to consider ECPR
as an alternative resuscitation method in patients with CCPR, and to find the indications for predicting good
neurologic outcome in OHCA patients who received ECPR.
Methods: This study is a retrospective analysis based on a prospective cohort. We included patients ≥ 18 years of
age without suspected or confirmed trauma and who experienced an OHCA from May 2006 to December 2013.
First, we determined the appropriate cut-off duration for CPR based on the discrimination of good and poor
neurological outcomes in the patients who received only CCPR, and then we compared the outcome between
the CCPR group and ECPR group by using propensity score matching. Second, we compared CPR related data
according to the neurologic outcome in matched ECPR group.
Results: Of 499 patients suitable for inclusion, 444 and 55 patients were enrolled in the CCPR and ECPR group,
respectively. The predicted duration for a favorable neurologic outcome (CPC1, 2) is < 21 minutes of CPR in only
CCPR patients. The matched ECPR group with ≥ 21 minutes of CPR duration had a more favorable neurological
outcome than the matched CCPR group at 3 months post-arrest. In matched ECPR group, younger age, witnessed
arrest without initial asystole rhythm, early achievement of mean arterial pressure ≥ 60 mmHg, low rate of
ECPR-related complications, and therapeutic hypothermia were significant factors for expecting good neurologic
outcome.
Conclusions: ECPR should be considered as an alternative method for attaining good neurological outcomes
in OHCA patients who required prolonged CPR, especially of ≥ 21 minutes. Younger or witnessed arrest patients
without initial asystole were good candidates for ECPR. After implantation of ECPR, early hemodynamic stabilization,
prevention of ECPR-related complications, and application of therapeutic hypothermia may improve the neurological
outcome.* Correspondence: kuedlee@korea.ac.kr
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The survival rate to discharge of out-of-hospital cardiac
arrest (OHCA) patients remains poor, despite decades of
advanced practice in conventional cardiopulmonary re-
suscitation (CCPR) [1-5]. The causes of high mortality
in OHCA are the failure to establish a return of spontan-
eous circulation (ROSC) and multiple organ failure, inclu-
ding hypoxic brain injury in patients receiving CCPR [6].
The rate of favorable neurological outcomes in OHCA
patients decreases according to the prolongation of CPR
duration [1]. Therefore, alternative resuscitative methods
may be necessary to improve survival, especially in patients
who require prolonged CPR [7].
The American Heart Association (AHA) recommended
the classification of extracorporeal cardiopulmonary re-
suscitation (ECPR) as an alternative method for patients
who have a brief no-flow time and a reversible cause of
cardiac arrest as Class IIb [8,9]. ECPR used as treatment
of cardiac arrest may preserve myocardial viability by en-
hancing coronary blood flow, thus increasing the chance
of ROSC [10]. As ECPR provides sufficient perfusion to
vital organs such as the brain and the injured myocar-
dium, the window of the duration of effective resuscitation
could be extended when using ECPR [11]. In addition,
ECPR may increase long-term survival by ensuring ad-
equate oxygenated blood delivery to end organs until an
effective cardiac output has been recovered, thus prevent-
ing organ failure.
There are few studies on the optimal time to consider
alternative resuscitation methods in OHCA patients who
receive prolonged CPR. Moreover, the advantage of ECPR
as an alternative method for attaining a good cerebral
performance category (CPC) score in OHCA patients
compared to CCPR is not well known.
We hypothesized that alternative methods may be con-
sidered after the optimal cutoff time due to the decreasing
rate of good neurological outcomes according to a pro-
longed duration of CPR. Additionally, after the estimated
cutoff time, an effective alternative method, such as ECPR
compared to CCPR, may show better neurological out-
comes. The primary goal of this study was to estimate the
optimal duration of CPR to consider ECPR as an alterna-
tive resuscitation method in patients with CCPR, and to
determine whether ECPR results in better neurological
outcomes than CCPR in patients who require prolonged
CPR beyond the optimal duration in OHCA patients. The
second goal was to find the indications for predicting good
neurologic outcome in patients who receive ECLS.
Materials and methods
Design and setting
This study was a retrospective analysis based on a pro-
spective cohort study that was conducted at the emer-
gency department (ED) of the Korea University MedicalCenter (KUMC), comprising 44 beds of the 890-bed uni-
versity teaching hospital, from May 2006 to December
2013. We analyzed the CPR registry that comprised
prospectively collected data on pre- and in-hospital vari-
ables of cardiac arrest patients who received CPR. The
Institutional Review Board (IRB) of KUMC approved the
data collection for the establishment of the CPR cohort
and informed consent for the CPR cohort and for ECPR
was also obtained prior to or after the institution of ECPR,
from the families of all cardiac arrest patients, respectively.
The IRB of KUMC approved this retrospective analysis
separately from establishment of the cohort.
Data collection of the CPR registry
A CPR coordinator prospectively collected data for the
CPR registry according to the Utstein style guideline [12].
The registry included demographic data; comorbidities;
whether the cardiac arrest was witnessed; the incidence of
suspected or confirmed trauma; presumed time of cardiac
arrest; presence of bystander CPR; first documented car-
diac arrest rhythm by the emergency medical service
(EMS) provider; any return of spontaneous circulation
(ROSC); presence of ECPR; the presence of return of
spontaneous heart beating (ROSB) after ECPR; presumed
cause of cardiac arrest; application of therapeutic hypo-
thermia, coronary angiography (CAG), or percutaneous
coronary intervention (PCI); 24-hour survival; the pres-
ence of ROSC for ≥20 minutes, hospital length of stay
(LOS) in survivors at discharge; CPC score at discharge
and 3 months post cardiac arrest; and the final diagnosis
at discharge. The CPC score at 3-months post cardiac
arrest was obtained from outpatient clinic medical record
review and telephone interviews conducted by the CPR
coordinator.
The comorbidity score was calculated using the Charl-
son comorbidity index [13]. The time intervals were cal-
culated from the registry. The interval between cardiac
arrest and start of CPR was defined as the time from
when the arrest was witnessed or found, to CPR started
by EMS providers, and the CPR duration was defined as
the time interval from the first chest compression pro-
vided by EMS providers to the termination of resuscita-
tion efforts either because of ROSC (for ≥20 minutes),
implantation of ECPR, or declaration of death [14]. If an
OHCA patient had recurrent cardiac arrest after gaining
ROSC (for ≥20 minutes), the first ROSC (≥20 minutes)
time was defined as the CPR stop-time. The CPR duration
consisted of pre-hospital CPR duration (CPR start to ED
presentation) and in-hospital CPR duration (ED presenta-
tion to CPR stop).
Indications and management of ECPR in the KUMC ED
The indications for ECPR in the KUMC ED during the
study period were 1) age ≥18 years; 2) sudden cardiac
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cardiac arrest with or without bystander CPR; or 4) no-
flow time (time interval from presumed arrest to CPR
started by the EMS provider) was expected to be short,
even for unwitnessed arrests. The initial cardiac arrest
rhythm documented pre-hospitalization was not consid-
ered as an indication for ECPR. The contraindications
for ECPR were 1) cardiac arrest due to a clearly uncor-
rectable cause; 2) presence of a terminal illness or malig-
nancy; 3) suspected or confirmed traumatic origin of
arrest; and 4) no informed consent from the family. The
ECPR team was activated by the emergency physician in
cases when OHCA patients met the inclusion criteria,
and required prolonged CPR more than 10 minutes as
in-hospital CPR duration or recurrently arrested in the
ED after achievement of ROSC (≥20 minutes). The time
from activating the ECPR team to implantation of
ECPR was 10 to 15 minutes during the day and 20 to
25 minutes during the night in our institution. ECPR was
implemented in the ED or coronary catheterization room.
All patients who experienced cardiac arrest received
advanced cardiac life support by emergency physicians
according to the AHA guidelines, excluding patients
with a do not attempt resuscitation (DNAR) order or
irreversible signs of death. The ECPR team consisted of
emergency physicians, cardiovascular surgeons, coronary
intervention specialists, and perfusionists. A twin-pulse
extracorporeal life support system (T-PLS®: NewHeartbio,
Seoul, Korea) or a Capiox emergency bypass system (EBS®;
Terumo Inc., Tokyo, Japan) were used for ECPR. Depend-
ing on the patient’s body size, a 15- to 17-Fr arterial and a
21 to 23-Fr venous catheter were inserted into the femoral
artery and vein percutaneously using Seldinger’s technique
while maintaining chest compressions. The flow rate was
initially set at 2.5 to 3.0 L/min. Anticoagulation with hep-
arin was given immediately after initiation of ECLS and
titrated to maintain an activated clotting time of 200 to
220 seconds.
Intra-arterial blood pressure and arterial blood gas
analysis at the radial artery were monitored. An intra-
aortic balloon pump was not used in the ED. After
implementation of ECPR, CAG was performed as soon
as possible in cases of suspected acute coronary syn-
drome (ACS).
ECPR was discontinued if spontaneous heart beating
was not obtained despite correction of the cause of car-
diac arrest. Withdrawal of ECPR was considered if there
was evidence of multiple organ failure, refractory shock,
or irreversible neurologic injury and with consent from
the patient’s family. A weaning protocol was instituted
after assessing hemodynamic profiles and myocardial
functions by echocardiography while progressively redu-
cing extracorporeal membrane oxygenation (ECMO)
flow of 1.5 L/min [15,16].Selection of study patients and outcome measurements
We enrolled the patients aged 18 years or older who
experienced OHCA, with no traumatic origin of cardiac
arrest, in the study from the CPR registry cohort. The
patients who were transferred from the ED to other hos-
pitals after ROSC and those who had missed the CPR
duration date were excluded (Figure 1). The primary end
point was a good neurological outcome (measured as a
CPC score of 1 or 2) at 3 months post cardiac arrest
[17]. The secondary end points were 24-hour survival
rate, survival to discharge, and survival rate at 3 months
post arrest.
Data analysis
Receiver operating characteristic (ROC) curve analysis of
CPR duration was used to differentiate between favorable
and unfavorable neurological outcomes in the CCPR group.
We compared good neurological outcomes by using a
Kaplan-Meier plot for ECPR and CCPR groups with CPR
duration longer than the estimated cut off duration. A
propensity-score-matching analysis was performed to
reduce the effects of selection bias and possible confound-
ing factors. The propensity score, which was the predicted
probability of receiving ECPR with covariates, was derived
through a logistic regression model. The covariates, in-
cluding age, sex, comorbidity score, bystander CPR,
witnessed cardiac arrest, first documented arrest rhythm,
presumed etiology of arrest, interval from arrest to CPR
started by EMS provider, CPR duration, and therapeutic
hypothermia, were used in propensity-score-matching.
Immediate CAG for only ACS suspected patients was not
matched at propensity-matching analysis, because our
patients had variable causes of cardiac arrest. ECPR and
CCPR cases were matched by their propensity score in
blocks of 1:1 and the selected patients formed well-
matched 1:1 pairs in both groups [15,16]. Model discrim-
ination was assessed with C statistics. We compared the
characteristics according to the good neurologic outcome
to find prognostic factors in matched ECPR group.
The data were reported as median with interquartile
range (IQR). Continuous variables were compared using
the Mann-Whitney test. Categorical variables were com-
pared using the chi-square or Fisher’s exact test. All statis-
tical analyses were carried out using SPSS version 20.0
(IBMSPSS Inc., Chicago, IL, USA) with the propensity-
score-matching program. Two-tailed P-values f <0.05 were
considered statistically significant.
Results
Characteristics, CPR variables and outcomes of the
unmatched ECPR and CCPR group
A total of 625 patients who received CPR due to OHCA
at ED were registered with the CPR registry during the
study period, of which 543 patients were enrolled in this
Figure 1 Selection of study patients and study design. KUED, Korea university emergency department; OHCA, out-of-hospital cardiac arrest;
DNAR, do not attempt resuscitation; CPR, cardiopulmonary resuscitation; ECPR, extracorporeal CPR group; CCPR, conventional CPR group; mECPR,
matched ECPR group; mCCPR, matched CCPR group; CPC, cerebral performance category.
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study group according to the selection criteria; 444
were included in the CCPR group and 55 in ECPR group
(Figure 1). The baseline characteristics and CPR variables
of both groups are shown in Table 1.
Patients in the ECPR group had significantly younger
age, lower comorbidity score, and higher incidence of
shockable rhythm as the first documented arrest rhythm
than those in the CCPR group. The CPR duration and
the incidence of presumed etiology of cardiac arrest was
longer and higher in the ECPR than in the CCPR group
(Table 1). A good neurological outcome at 3 monthspost arrest did not show any significant difference be-
tween groups (Table 1).
The trend of outcomes according to the CPR duration in
both unmatched groups
The rates of ROSC or ROSB, 24-hour survival, survival
rate at 3 months post cardiac arrest, and good neuro-
logical outcome (CPC 1, 2) at 3 months post arrest tended
to decrease more sharply in the CCPR than in the ECPR
group according to the prolongation of CPR duration
(Figure 2).
Table 1 Comparison of characteristics between the ECPR group and CCPR group
ECPR (n = 55) CCPR (n = 444) P-value
Age, years 53 (41 to 68) 69 (56 to 77) <0.001
Male : female, n 41 : 14 285 : 159 0.136
Pre-existing comorbidity, n (%)
Hypertension 14 (25.5) 161 (36.3) 0.134
Cardiovascular disease 15 (27.3) 101 (22.7) 0.498
Chronic pulmonary disease 1 (1.8) 33 (7.4) 0.157
Neurologic disease 3 (5.5) 67 (15.1) 0.062
Chronic liver disease 1 (1.8) 20 (4.5) 0.495
Chronic kidney disease 1 (1.8) 41 (9.2) 0.070
Diabetes 11 (20.0) 122 (27.5) 0.262
Malignancy 1 (1.8) 38 (8.6) 0.106
Number of pre-existing comorbidities 0 (0 to 1) 1 (0 to 2) 0.003
Comorbidity score 0 (0 to 1) 1 (0 to 2) <0.001
Witnessed, n (%) 43 (78.2) 328 (73.9) 0.623
Bystander CPR, n (%) 23 (41.8) 151 (34.0) 0.294
First documented arrest rhythm, n (%) <0.001
VF/VT 31 (56.4) 85 (19.1)
PEA 10 (18.2) 91 (20.5)
Asystole 14 (25.5) 268 (60.4)
Arrest to CPR start, minutes 7 (0 to 13) 8 (5 to 12) 0.108
CPR duration, minutes 62 (47 to 89) 35 (21 to 50) <0.001
Pre-hospital CPR duration 13 (7 to 17) 13 (8 to 17) 0.930
In-hospital CPR duration 47 (35 to 80) 21 (8 to 35) <0.001
Presumed etiology of arrest, n (%) <0.001
Cardiac 49 (89.1) 277 (62.4)
Non-cardiac 6 (10.9) 167 (37.6)
At the time of admission to ED
SAPS II* 91 (87 to 97) 97 (91 to 103) <0.001
Arterial pH* 6.98 (6.86 to 7.05) 6.94 (6.83 to 7.06) 0.473
Serum lactate* 11.7 (8.8 to 16.0) 10.8 (7.3 to 14.0) 0.083
Any ROSC events during CPR, n (%) 17 (30.9) 94 (21.2) 0.121
Therapeutic hypothermia, n (%) 17 (30.9) 71 (16.0) 0.013
ROSB/ROSC, n (%) 44 (80.0) 212 (47.7) <0.001
Survival to 24 hours, n (%) 32 (58.2) 138 (31.1) <0.001
CPC score at discharge 0.226
1, n (%) 7 (12.1) 30 (6.8)
2, n (%) 1 (1.8) 6 (1.4)
3, n (%) 0 (0) 8 (1.8)
4, n (%) 1 (1.8) 42 (9.5)
5, n (%) 46 (83.6) 358 (80.6)
Hospital LOS in survival to discharge, day 30 (14 to 60) 18 (9 to 30) 0.120
Survivor at 3 months after arrest, n (%) 8 (14.5) 44 (9.9) 0.346
CPC 1,2 at 3 months after arrest, n (%) 8 (14.5) 36 (8.1) 0.128
Data are shown as median (interquartile range) or number (%). *Measured in 48 ECPR patients and 332 CCPR patients. CPR, cardiopulmonary resuscitation; ECPR,
extracorporeal CPR; CCPR, conventional CPR; VF, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity; ED, emergency department;
SAPS, simplified acute physiologic score; ROSB, return of spontaneous heart beat; ROSC, return of spontaneous circulation; CPC, cerebral performance category;
LOS, length of stay.
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Figure 2 Trends of outcomes in the conventional cardiopulmonary resuscitation (CCPR) and extracorporeal cardiopulmonary
resuscitation (ECPR) groups according to the cardiopulmonary resuscitation (CPR) duration. In the ECPR group, the longest CPR duration
with a good neurologic outcome was 120 minutes. CPC, cerebral performance category.
Figure 3 Receiver-operating characteristic (ROC) curves for the
cutoff time of cardiopulmonary resuscitation (CPR) duration for
predicting a good neurological outcome in the conventional
cardiopulmonary resuscitation (CCPR) group (P <0.001). The
cutoff value was 21 minutes. AUC, area under the curve.
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outcome in the CCPR group
Using a ROC-curve analysis of the CCPR group (n = 444),
the best discriminative CPR duration for a favorable neu-
rological outcome was 21 minutes (area under the curve
0.925, 95% CI 0.889, 0.961, P <0.001) (Figure 3).
Comparison of ECPR and CCPR group survival analysis in
patients with CPR duration ≥21 minutes
Survival analysis using a Kaplan-Meier plot showed more
favorable neurological outcomes in the ECPR than in the
CCPR group at 3 months post cardiac arrest among
patients with a CPR duration ≥21 minutes (stratified log-
rank test, P <0.001) (Figure 4).
Outcome analysis of propensity-score-matched groups
(in cases of CPR duration ≥21 minutes)
The c-statistic of the propensity-score model was 0.999,
and the median propensity scores in the ECPR and
CCPR groups were 0.39 (SD 0.14) versus 0.10 (SD 0.14),
respectively, before matching and 0.39 (SD 0.20) versus
0.34 (SD 0.20), respectively, after matching (Figure 5).
The confounding factors of the characteristics were
balanced and there were no significant differences in the
matched groups (Table 2). The median value of CPR dur-
ation was 63 minutes (IQR 50 to 88) and 61 minutes (IQR
40 to 84) in the matched ECPR group (mECPR) and the
matched CCPR group (mCCPR), respectively. Application
of therapeutic hypothermia (TH) was not different between
mECPR and mCCPR (P = 0.821). CAG for suspected acute
coronary disease was more frequent in mECPR thanmCCPR (P = 0.213) (Table 3). The rate of 24-hour survival
and a favorable neurological outcome at 3 months post
cardiac arrest in the mECPR group were significantly
higher than those in the mCCPR group, although the
rate of survival to discharge was similar in both groups
(Figure 6).
Figure 4 Kaplan-Meier plot of survival with a good neurological
outcome at 3 months post cardiac arrest for patients who
experienced out-of-hospital cardiac arrest (OHCA) with
cardiopulmonary resuscitation (CPR) duration ≥21 minutes. The
extracorporeal CPR (ECPR) group showed better neurological
outcomes compared to the conventional CPR (CCPR) group at 3
monthS post arrest.
Figure 5 Dot-plot of standardized mean differences before and
after matching in study patients with a cardiopulmonary
resuscitation (CPR) duration ≥21 minutes. ROSC = return of
spontaneous circulation.
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outcome in the mECPR group
Of 52 mECPR patients, 8 patients received ECPR due to
recurrent cardiac arrest following ROSC (≥20 minutes).
The median CPR duration and median time interval
from ROSC to ECPR implantation was 68.5 (range 32 to
136) hours and 1.5 (range 0.6 to 6.4) hours, respectively.
Younger age and witnessed arrest without initial asystole
were significant indicators for predicting good neuro-
logic outcome in the mECPR group (Table 3). The CPR
duration of the group with good neurologic outcome
tended to be short compared with those with poor
neurologic outcome (P = 0.432). The rates of mean ar-
terial pressure (MAP) ≥60 mmHg within 2 hours post
ECPR and the application of therapeutic hypothermia
were higher, and the rates of ECPR-related complications
were lower in the group with CPC 1 and 2 than in the
group with CPC 3 to 5 (Table 4). Inotropic equivalent
dose was higher in the group with CPC 3 to 5 than in the
group with CPC 1 and 2 (Table 4) [18]. The rate of the pa-
tients without any coronary lesions was higher in the
group with good neurologic outcome. (Table 5).
Upper limitation of CPR duration in the ECPR implantation
group for expecting a good neurologic outcome
Because there was no significant difference in CPR
duration between good neurologic outcome and poor
outcome in the mECPR group (Table 3), we compared
neurologic outcomes in the mECPR and mCCPR groupsaccording to the CPR duration (Figure 7). There was no
difference in neurological outcome between mECPR and
mCCPR when the CPR duration was 21 to 40 minutes.
However, mECPR showed a higher rate of good neuro-
logical outcomes with 21 to 80 minutes of CPR duration
than mCCPR (P = 0.026).
Discussion
This study is one of the few using propensity score for
evaluating the impact of ECPR for OHCA. In this study
the CCPR group tended to show decreased rates of
ROSC, 24-hour survival, survival and good neurological
outcome at 3 months post cardiac arrest as the CPR dur-
ation increased. In particular, the rate of good neurological
outcomes significantly decreased after CPR duration of
21 minutes. The survival analysis for the OHCA patients
Table 2 Comparison of the characteristics between the mECPR and mCCPR groups
mECPR (n = 52) mCCPR (n = 52) P-value
Age, years 54 (41 to 69) 54 (42 to 68) 0.871
Male : female, n 40 : 12 38 : 14 0.821
Pre-existing comorbidity, n (%)
Hypertension 13 (25.0) 12 (23.1) 1.000
Cardiovascular disease 15 (28.8) 11 (21.2) 0.497
Chronic pulmonary disease 1 (1.9) 0 (0.0) 1.000
Neurologic disease 3 (5.8) 4 (7.7) 1.000
Chronic liver disease 1 (1.9) 2 (3.8) 1.000
Chronic kidney disease 1 (1.9) 3 (5.8) 0.618
Diabetes 11 (21.2) 6 (11.5) 0.289
Malignancy 1 (1.9) 2 (3.8) 1.000
Number of pre-existing comorbidities 1 (0 to 2) 1 (0 to 1) 0.695
Comorbidity score 0 (0 to 1) 0 (0 to 1) 0.692
Witnessed, n (%) 42 (80.8) 42 (80.8) 1.000
Bystander CPR, n (%) 22 (42.3) 22 (30.8) 1.000
First documented arrest rhythm, n (%) 0.639
VF/VT 31 (59.6) 29 (55.8) 0.901
PEA 8 (15.4) 8 (15.4)
Asystole 13 (25.0) 15 (28.8)
Arrest to CPR start, minutes 7.0 (0.3 to 12.8) 7.0 (5.0 to 10.0) 0.507
CPR duration, minutes 62.5 (49.0 to 88.0) 60.5 (40.0 to 83.5) 0.387
Pre-hospital CPR duration 13.0 (7.0 to 17.0) 13.0 (9.3 to 16.8) 0.677
In-hospital CPR duration 47.5 (35.3 to 76.8) 48.0 (25.3 to 71.0) 0.550
Presumed etiology of arrest, n (%) 1.000
Cardiac 49 (94.2) 49 (94.2)
Suspected ACS 44 (84.6) 46 (88.5)
Non-cardiac 3 (5.8) 3 (5.8)
At the time of admission to ED
SAPS II* 91 (87 to 98) 91 (88 to 96) 0.695
Arterial pH* 6.98 (6.86 to 7.05) 6.97 (6.90 to 7.05) 0.487
Serum lactate* 11.6 (8.6 to 15.3) 10.8 (8.8 to 15.0) 0.460
Any ROSC events during CPR, n (%) 16 (30.8) 17 (32.7) 1.000
Data are shown as median (IQR) or number (%). *Measured in 48 mECPR and 47 mCCPR patients. CPR, cardiopulmonary resuscitation; ECPR, extracorporeal CPR;
CCPR, conventional CPR; VF, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity; ED, emergency department; ACS, acute coronary
syndrome; SAPS, simplified acute physiologic score; ROSC, return of spontaneous circulation.
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logical outcome at 3 months post arrest in the ECPR
compared to the CCPR group. Using propensity-score
matching, the mECPR group, compared with the mCCPR
group showed an improved neurological outcome at
3 months post arrest, despite the survival to discharge
rate not showing any difference between groups. In
the mECPR group, younger age patients, with witnessed
cardiac arrest, who had no asystole as an initial arrest
rhythm, were good candidates for ECPR. In addition, early
achievement of mean arterial pressure (MAP) ≥60 mmHg,therapeutic hypothermia, and low incidence of ECPR-
related complications were significant factors for good
neurologic outcome in the mECPR group.
As the CCPR duration becomes longer, optimal per-
fusion cannot be maintained until the underlying car-
diac defect is corrected. Consequently, prolonged CPR
is associated with a poor outcome [1,2,15,19,20]. Our
study showed that the probability of survival to dis-
charge, especially with a good neurological outcome
tends to decrease with longer CPR duration in the
CCPR group.
Table 3 Comparison of post-resuscitation care and outcomes between the mECPR and mCCPR groups
mECPR (n = 52) mCCPR (n = 52) P-value
Rate of ROSB/ROSC (≥20 minutes), n (%) 42 (80.8) 20 (38.5) < 0.001
Therapeutic hypothermia, n (%) 14 (26.9) 12 (23.1) 0.821
CAG in patients with suspected ACS (%) 39 in 44 (88.6) 11 in 15 (73.3)* 0.213
CAG findings n = 39 n = 11 0.010
No significant coronary lesion 5 (12.8) 4 (36.4)
Coronary spasm 3 (7.7) 4 (36.4)
Presence of coronary occlusion/stenosis, n (%) 31 (79.5) 3 (27.3)
Diseased coronary artery, n (%) n = 31 n = 3 0.603
1 vessel 23 (74.2) 3 (100)
2 vessels 5 (16.1) 0 (0)
3 vessels 3 (9.7) 0 (0)
PCI for coronary occlusion/stenosis 29 (93.5) 3 (100) 1.000
CPC score at discharge 0.011
1, n (%) 7 (13.5) 1 (1.9)
2, n (%) 1 (1.9) 0
3, n (%) 0 2 (3.8)
4, n (%) 1 (1.9) 8 (15.4)
5, n (%) 43 (82.7) 41 (78.8)
Hospital LOS in survival to discharge, days 30 (14 to 60) 28 (16 to 50) 0.766
CPC score at 3 months post arrest 0.070
1, n (%) 7 (13.5) 1 (1.9)
2, n (%) 1 (1.9) 0 (0)
3, n (%) 0 (0) 2 (3.8)
4, n (%) 0 (0) 1 (1.9)
5, n (%) 44 (84.6) 48 (92.3)
Final diagnosis of arrest, n (%) < 0.001
Cardiac
ACS/AMI 36 (69.2) 9 (17.3)
Lethal arrhythmia 3 (5.8) 5 (9.6)
HF, HCMP, DCMP 3 (5.8) 2 (3.8)
Pulmonary embolism 2 (3.8) 1 (1.9)
Unknown sudden arrest 4 (7.7) 31 (59.6)
Non-cardiac
Respiratory arrest 1 (1.9) 0 (0)
Hypothermia 1 (1.9) 0 (0)
Acute kidney injury 1 (1.9) 3 (5.8)
Brain hemorrhage 1 (1.9) 1 (1.9)
Causes of death at 3 months post arrest, n (%) n = 44 n = 48 < 0.001
No ROSB or ROSC 10 (22.7) 32 (66.7)
Refractory shock 24 (54.5) 4 (8.4)
Hypoxic brain injury and organ failure 8 (18.2) 12 (25.0)
Brain death 2 (4.5) 0 (0)
Data are shown as median (IQR) or number (%). *In 15 suspected ACS patients with ROSC (≥20 minutes). CPR, cardiopulmonary resuscitation; ECPR, extracorporeal
CPR; CCPR, conventional CPR; ROSB, return of spontaneous heart beat; ROSC, return of spontaneous circulation; CAG, coronary angiography; ACS, acute coronary
syndrome; PCI, percutaneous coronary intervention; CPC, cerebral performance category; LOS, length of stay; HF, heart failure; HCMP, hypertrophic cardiomyopathy;
DCMP, dilated cardiomyopathy.
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Figure 6 Outcomes of the matched extracorporeal cardiopulmonary resuscitation (mECPR) and matched conventional cardiopulmonary
resuscitation (mCCPR) groups after propensity-score-matching in patients with cardiopulmonary resuscitation (CPR) duration ≥21 minutes.
CPC, cerebral performance category.
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with failed CCPR, ECPR can provide an alternative the-
rapeutic option to improve the chances of rapid return
of circulation and survival with good neurological
outcome [4,14,21,22]. Whether determining an optimal
transition time of CPR duration before deploying ECPR
results in a better neurological outcome than CCPR
remains unknown. Reynolds et al. reported that alterna-
tive methods should be considered within 16.1 minutes
of total CPR duration from chest compression by the
EMS provider [1]. However, we have stepped even fur-
ther and determined that 21 minutes from CPR start by
the healthcare provider is an acceptable cutoff time for
the CPR duration in predicting a good neurological out-
come in the patients who receive only CCPR. In this
study, the ECPR group showed a better neurological
outcome at 3 months post arrest compared to the CCPR
group in patients with a CPR duration ≥21 minutes.
This result was similar with the guidelines for indica-
tions for the use of ECPR by French medical scientific
societies, which recommended that a refractory cardiac
arrest prolonged for 30 minutes results in a poor chance
of obtaining good neurological outcomes, and ECPR
should be considered [14].
ECPR requires many medical resources and has several
limitations; primarily, it requires adequate indications
for implementation. French medical scientific societies
recommended that it is not appropriate to consider extra-
corporeal life support when CPR has lasted less than
15 minutes [14]. In this study, a good neurological out-
come occurred in 31.7% of patients in the CCPR group
with a CPR duration <21 minutes. Three patients during
our experiment received ECPR due to recurrent arrest
after achievement of early ROSC (≥20 minutes) within
20 minutes of CPR duration. However, they have allexpired. The importance and advantage of CCPR during
a short low-flow time (CPR duration) cannot be replaced
by using ECPR.
In this study, there were no differences in the interval
from cardiac arrest to CPR start and CPR duration
between the group with CPC 1, 2 and the group with CPC
3 to 5 among the mECPR group. Time interval from CPR
start to ECPR implantation is also important to outcomes
among OHCA patients who required prolonged CPR.
Leick et al. reported that a door-to-ECPR implantation
time of <30 minutes, and not just total CPR duration,
had a benefit of 1-month survival in ECPR patients [23].
Fagnoul et al. reported that good outcome can be ob-
tained in 15 to 20% of patients, provided that time from
arrest to ECPR flow is shorter than 60 minutes [24]. In
this study, CPR duration of 21 to 80 minutes resulted in a
good neurologic outcome for 19.4% of patients in the
mECPR group. If we consider ECPR as an alternative
method after 21 minutes of CPR duration, the time of
ECPR implantation will be after 40 minutes of CPR
duration, due to the time interval from the call for team
activation to ECPR implantation. The patients with CPR
duration of 41 to 80 minutes showed better neurologic
outcome in the mECPR than in the mCCPR group, except
the one patient with the longest CPR duration of 120 mi-
nutes. This case was previously reported [25]. Our study
suggests that OHCA patients who do not respond to con-
ventional CPR given by the healthcare provider within
21 minutes must be considered for ECPR as an alternative
method, and earlier implantation of ECPR may be better
for expecting a good neurologic outcome, because the rate
of good neurological outcomes tend to decrease as the
CPR duration increases, even in the mECPR group.
Although this study focused on the CPR duration,
many other covariates, including no-flow time, initial
Table 4 Comparison of the baseline characteristics according to good neurologic outcome in the mECPR group (n = 52)
CPC 1, 2 (n = 8) CPC 3 to 5 (n = 44) P-value
Age, years 37 (22 to 54) 56 (43 to 70) 0.014
Male : female, n 7 : 1 33 : 11 0.663
Pre-existing comorbidity, n (%)
Hypertension 0 (0) 13 (29.5) 0.177
Cardiovascular disease 2 (25.0) 13 (29.5) 1.000
Chronic pulmonary disease 0 (0) 1 (2.3) 1.000
Neurologic disease 0 (0) 1 (2.3) 1.000
Chronic liver disease 0 (0) 1 (2.3) 1.000
Chronic kidney disease 0 (0) 1 (2.3) 1.000
Diabetes 1 (12.5) 10 (22.7) 1.000
Malignancy 1 (12.5) 0 (0) 0.154
Number of pre-existing comorbidities 0 (0 to 1) 1 (0 to 2) 0.135
Comorbidity score 0 (0 to 1) 0 (0 to 1) 0.367
Witnessed, n (%) 8 (100) 34 (77.3) 0.328
Bystander CPR, n (%) 5 (62.5) 17 (38.6) 0.260
First documented arrest rhythm, n (%) 0.191
VF/VT 6 (75.0) 25 (56.8)
PEA 2 (25.0) 6 (13.6)
Asystole 0 (0) 13 (29.5)
Arrest to CPR start, minutes 6.0 (1.0 to 13.8) 7.0 (0.3 to 12.8) 0.794
CPR duration, minutes 57.0 (52.3 to 65.8) 67 (49 to 94) 0.432
Pre-hospital duration 14.0 (11.0 to 19.0) 13.0 (6.0 to 17.0) 0.525
In-hospital duration 38.5 (31.8 to 51.0) 51.0 (37.0 to 82.5) 0.233
Any ROSC events during CPR 4 (50.0) 12 (27.3) 0.231
At the time of admission to ED
SAPS II* 87 (85 to 94) 91 (88 to 98) 0.140
arterial pH* 6.90 (6.81 to 7.04) 6.98 (6.86 to 7.05) 0.373
Serum lactate* 11.2 (9.3 to 16.5) 11.5 (8.5 to 14.9) 0.766
Reason for ECPR 0.593
Refractory arrest, n (%) 6 (75.0) 38 (86.4)
Recurrent arrest, n (%) 2 (25.0) 6 (13.6)
Location of ECPR implantation
ED : catheterization room, n 2 : 6 18 : 26 0.463
Final diagnosis of arrest, n (%) 0.191
Cardiac 8 (100) 40 (90.3)
ACS/AMI 5 (62.5) 31 (70.5)
Lethal arrhythmia 2 (25.0) 1 (2.3)
HF, HCMP, DCMP 0 (0) 3 (6.8)
Pulmonary embolism 1 (12.5) 1 (2.3)
Unknown sudden arrest 0 (0) 4 (9.1)
Non-cardiac 0 (0) 4 (9.1)
Respiratory arrest 0 (0) 1 (2.3)
Hypothermia 0 (0) 1 (2.3)
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Table 4 Comparison of the baseline characteristics according to good neurologic outcome in the mECPR group (n = 52)
(Continued)
Acute kidney injury 0 (0) 1 (2.3)
Brain hemorrhage 0 (0) 1 (2.3)
Witnessed + no asystole 8 (26.7) 0 (0) 0.015
Data are shown as median (IQR) or number (%). *Measured in eight patients with CPC 1, 2 and 40 patients with CPC 3 to 5. CPR, cardiopulmonary resuscitation;
ECPR, extracorporeal CPR; VF, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity; ED, emergency department; SAPS, simplified acute
physiologic score; ROSC, return of spontaneous circulation; ACS, acute coronary syndrome; AMI, acute myocardial infarction; HF, heart failure; HCMP, hypertrophic
cardiomyopathy; DCMP, dilated cardiomyopathy.
Kim et al. Critical Care 2014, 18:535 Page 12 of 15
http://ccforum.com/content/18/5/535arrest rhythm, causes of arrest, refractory arrest or re-
arrest, and post-resuscitation care will affect the good
neurologic outcome from ECPR. In this study, age was a
significant variable for predicting good neurologic outcome
in the mECPR group. Among our neurologically intact
survivors, the oldest age was 82 years in the CCPR group
and 62 years in the ECPR group. Although we could not in-
dicate the absolute age criterion for ECPR in cardiac arrest,Table 5 Comparison of post-ECPR care according to the neuro
CPC 1, 2
ROSB after ECPR 8 (100)
MAP ≥60 mmHg within 2 hrs after ECPR, n (%) 8 (100)
Number of infused vasopressor/inotropics, n 2 (1 to 3
Inotropic equivalent, μg/kg/min for 2 hrs post ECPR 32 (10 to
LVEF after ECPR implantation 33 (18 to
Therapeutic hypothermia, n (%) 5 (62.5)
ROSB to target temperature (33 °C), hrs 4 (2 to 6
Time on target temperature, hrs 24 (21 to
CAG in patients with suspected ACS, n (%) 7 in 7 (1
CAG findings n =7
No significant coronary lesion 2 (28.6)
Coronary spasm, n (%) 0 (0)
Coronary occlusion/stenosis, n (%) 5 (71.4)
Diseased coronary artery, n (%) n = 5
1 vessel 4 (80.0)
2 vessels 1 (20.0)
3 vessels 0 (0)
PCI for coronary occlusion/stenosis 5 (100)
Complications during ECLS, n (%) 0 (0)
Bleeding at access site -
Lower limb ischemia -
Intracranial hemorrhage -
Anterograde reperfusion catheter, n (%) 11 ( 25.0
Amount of transfused pRBC 5 (3 to 1
Successful weaning form ECLS, n (%) 8 (100)
Duration of ECLS, hrs 43.6 (29.
Data are shown as median (IQR) or number (%). CPR, cardiopulmonary resuscitation
ventricle ejection fraction; CAG, coronary angiography; ACS, acute coronary syndrom
pRBC, packed red blood cells.younger age might have a more favorable outcome. Previ-
ous comorbidity is important to the outcomes of OHCA
patients. In this study, there was no difference in comorbid-
ities or SAPS II score between the groups with CPC 1, 2
and CPC 3 to 5 in the mECPR group, because we only con-
sidered patients without a serious comorbidity for ECPR.
The AHA recommended ECPR for patients who have
a brief no-flow time [8,9]. In this study, no survivor withlogic outcome in the mECPR group (n = 52)
(n = 8) CPC 3 to 5 (n = 44) P-value
34 (81.0) 0.328
25 (56.8) 0.021
) 2 (1 to 2) 0.945
74) 59 (15 to 82) 0.180
48) 10 (0 to 20) 0.009
9 (20.5) 0.025
) 2.8 (1.6 to 3.0) 0.222 0.435
24) 24 (24 to 41)
00) 32 in 37 (86.5) 0.574













) 2 (25.0) 1.000
2) 5 (1 to 10) 0.833
2 (4.5) <0.001
7 to 92.8) 17.9 (3.7 to 48.7) 0.026
; ECPR, extracorporeal CPR; ROSB, return of spontaneous heart beat; LVEF, left
e; PCI, percutaneous coronary intervention; ECLS, extracorporeal life support;
Figure 7 Comparison of the rate of good neurologic outcomes in the matched extracorporeal cardiopulmonary resuscitation (mECPR)
and matched conventional cardiopulmonary resuscitation (mCCPR) groups according to the cardiopulmonary resuscitation (CPR)
duration. CPR duration between 21 to 80 minutes showed that mECPR had a significantly greater rate of good neurologic outcomes (CPC 1, 2).
CPC, cerebral performance category.
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tients with both asystole and unwitnessed cardiac arrest.
The no-flow time may be increased among patients with
unwitnessed arrest. In addition, asystole may be the last
rhythm of the arrest [26]. Serum lactate or arterial pH
reflects the severity of tissue hypoxia. In this study, the
levels of serum lactate and arterial pH were not different
between ECPR and CCPR (Table 1), and between groups
with CPC 1, 2 group and CPC 3 to 5 in the mECPR
group, respectively (Table 3). We have theorized that the
longer time interval from arrest to ED presentation
influenced the high levels of serum lactate and develop-
ment of acidosis in each group.
Post-resuscitation care is also important to the out-
comes of OHCA patients. Mollmann et al. reported that
early invasive treatment after CPR, irrespective of the
underlying cause of cardiac arrest, leads to considerably
reduced mortality and improved prognosis in patients
after OHCA [27]. In our study, many patients undergoing
mCCPR expired during CPR or early in the post-ROSC
period. The chance of receiving immediate CAG was
limited in the mCCPR group. Therefore, the incidence of
coronary artery with occlusion or stenosis was lower in
the mCCPR than in the mECPR group. However, most
patients in the mECPR group immediately received CAG
under the support of ECLS when they were suspected of
having acute coronary syndrome. ECPR will enhance the
opportunity for correction of the cause of cardiac arrest
by supporting the essential circulation.
In this study, early achievement of hemodynamic
stability after ECPR and application of therapeutic hy-
pothermia were significant factors for good neurologicoutcomes among the mECPR group: mECPR patients
with CPC 3 to 5 had a high incidence of shock in spite
of high-dose infusion of inotropics. We thought that this
might be a result of the low incidence of ROSB and low
LVEF in mECPR patients with CPC 3 to 5. Hemodynamic
instability precluded the application of therapeutic hypo-
thermia. The most common complication during ECPR
was bleeding at the access site, possibly related to the tech-
nique of catheter insertion. We used methods of sono-
guided catheter insertion in the ED and fluoroscope-guided
catheter insertion in the catheterization room. In this study,
there was no difference in neurologic outcome according to
the location of ECPR implantation in the mECPR group.
Limitations
This study has several limitations that require consider-
ation. First, this was a non-randomized observational
cohort study from retrospective analysis in a single cen-
ter. Pertinent indication criteria of ECPR have not been
established and the protocol has been not standardized;
it differs according to the emergency medical services
(EMS) and in-hospital system. All studies on ECPR, in-
cluding our study, have different inclusion criteria and
methods of intervention and analysis under different
healthcare environments. Therefore, the transition time
for considering ECPR may be changeable according to
the definition of CPR duration or different EMS service
system. Our study suggests that the physician who works
with ECPR has to find the specific transition time
for ECPR that suits their EMS system. Second, the upper
limit of CPR duration for ECPR implantation was
not clearly revealed in this study. The small cohort
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tical significance. It may be necessary to perform a pro-
spective multi-center, randomized controlled study with
a clear protocol to determine the precise difference be-
tween neurological outcomes with ECPR and CCPR.
Third, the standard CPR guideline has been changed
during the study period. The change of guideline
might affect the CPR performance in this study group.
Before 2010 therapeutic hypothermia was not frequently
used. Indeed, we avoided the induction of hypothermia,
which could improve neurologic recovery, in ECPR pa-
tients during 2006 to 2008, because of concerns about
hypothermia inducing unstable vital signs and tendency
for bleeding. After the introduction of the 2010 AHA
guideline, therapeutic hypothermia was more frequently
applied post resuscitation in CCPR and ECPR patients [4].
Fourth, we compared the outcomes of the mECPR and
the mCCPR groups under identical inclusion criteria after
matching. However, several variables might not be identi-
cally matched and unmeasured bias may remain despite
the use of propensity-score-matching. In this study, the in-
cidence of TH in the mCCPR group was lower compared
with that in the mECPR group. However, the rate of TH
in patients with ROSC or ROSB was high with mCCPR
compared to mECPR.
Conclusions
A good neurological outcome declined with prolonged
CPR duration. ECPR should be considered as an alterna-
tive method for attaining good neurological outcomes in
OHCA patients who require prolonged CPR, especially
CPR ≥21 minutes. Younger patients, with witnessed car-
diac arrest without initial asystole were good candidates
for expecting good neurologic outcome from ECPR. After
implantation of ECPR, early hemodynamic stabilization,
prevention of ECPR-related complications, and applica-
tion of therapeutic hypothermia may improve the neuro-
logic outcome.
Key messages
 Good neurologic outcome can be expected
when we transit from CCPR to ECPR, especially in
patients requiring prolonged CPR, particularly for
CPR duration of ≥21 minutes
 Younger age patients with witnessed cardiac
arrest without initial asystole were good
candidates for ECPR in OHCA patients who
required prolonged CPR
 After implantation of ECPR, early achievement
of hemodynamic stability, prevention of
ECPR-related complication, and therapeutic
hypothermia improved the neurologic
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